SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme 
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO 
REPAY Stock Rises After Visa Platform Connect Collaboration 
Samsung Eyes $72 Billion Shareholder Return Plan as AI Chip Boom Fuels Profits 
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead 
Amazon to Expand Drone Delivery to 500 U.S. Locations 
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars 
Welspun Corp Shares Hit Record High on $1.8 Billion U.S. Order 
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion 
Apple Cuts Over 200 Siri, Vision Pro Jobs in AI Shift 
Alibaba Shares Fall as AI Spending Hits Profit 
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut 
Baidu Shares Sink to One-Year Low as Ad Weakness Overshadows AI Growth 
Standard Chartered Expands Hedge Fund Access for Wealth Clients 
Barclays Downgrades Renault as Cost Savings Challenges Grow 
Nvidia AI Server Prices Set to Rise as Memory Costs Surge 
Add as a preferred source on Google
LAS VEGAS, May 08, 2018 -- CV Sciences, Inc., (OTCQB:CVSI) a preeminent manufacturer and distributor of hemp-derived phytocannabinoids including CBD oil, today announced that it is scheduled to host a conference call to discuss its first quarter 2018 financial results on Tuesday, May 15, 2018 at 1:15pm PT / 4:15pm ET.
CV Sciences’ CFO Joseph Dowling will lead the call to provide an operational and financial summary of the first quarter ended March 31, 2018. Interested parties may access the live webcast by visiting: https://78449.themediaframe.com/dataconf/productusers/cvsciences/mediaframe/24633/indexl.html
In order to ensure adequate time for any software downloads that may be necessary to listen to the webcast, attendees are encouraged to connect to the website 10-15 minutes prior to the live event.
Participants may also access the listen-only audio call by dialing 1-877-407-8293 (United States) or 1-201-689-8349 (International). If you are unable to participate in the call at this time, a replay will be available for 14 days starting on May 15, 2018, at approximately 7:30 p.m. PT/10:30 p.m. ET. To access the replay, please dial 1-877-660-6853 in the U.S. and 1-201-612-7415 for international callers. The conference ID# is 13679917.
About CV Sciences, Inc.
CV Sciences, Inc (OTCQB:CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
CONTACT INFORMATION:
Robert Haag
Managing Director
IRTH Communications
[email protected]
866-976-4784
